| Q90743882 | A multiparametric organ toxicity predictor for drug discovery |
| Q47648812 | Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. |
| Q34322013 | Alterations in Hepatic mRNA Expression of Phase II Enzymes and Xenobiotic Transporters after Targeted Disruption of Hepatocyte Nuclear Factor 4 Alpha |
| Q53487386 | Analysis of Human Cytochrome P450 Catalytic Activities and Expression |
| Q71786792 | Analysis of cis-acting regions upstream of the rat Na+/K+-ATPase α1 subunit gene by in vivo footprinting |
| Q27311598 | Chemogenetic disconnection of monkey orbitofrontal and rhinal cortex reversibly disrupts reward value. |
| Q114870004 | Creatine riboside is a cancer cell–derived metabolite associated with arginine auxotrophy |
| Q34513706 | Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models |
| Q42944154 | Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice |
| Q44403612 | Expression of the Human CYP3A4 Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam |
| Q112722593 | Feeding-induced resistance to acute lethal sepsis is dependent on hepatic BMAL1 and FXR signalling |
| Q33687018 | Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation |
| Q58611521 | Gut microbiota and intestinal FXR mediate the clinical benefits of metformin |
| Q92094154 | Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome |
| Q44643518 | Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1α)-deficient mice |
| Q44635530 | Hepatocyte Nuclear Factor 4α Is a Central Regulator of Bile Acid Conjugation |
| Q42953260 | High Density Lipoprotein Turnover is Dependent on Peroxisome Proliferator-Activated Receptor α in Mice |
| Q90440705 | Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice |
| Q98227085 | Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice |
| Q37415763 | Identification and characterization of PPARα ligands in the hippocampus |
| Q92387117 | Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity |
| Q114870722 | Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis |
| Q36379436 | Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction |
| Q102141528 | Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting |
| Q30929618 | Microarray Analysis Using Amplified mRNA from Laser Capture Microdissection of Microscopic Hepatocellular Precancerous Lesions and Frozen Hepatocellular Carcinomas Reveals Unique and Consistent Gene Expression Profiles |
| Q125903556 | Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target |
| Q35272037 | Mouse cytochrome P3-450: complete cDNA and amino acid sequence |
| Q41354947 | Oxidative metabolism of bunitrolol by complementary DNA-expressed human cytochrome P450 isozymes in a human hepatoma cell line (Hep G2) using recombinant vaccinia virus |
| Q34322065 | PPARα-Dependent Activation of Cell Cycle Control and DNA Repair Genes in Hepatic Nonparenchymal Cells |
| Q34482267 | Pregnane X receptor-mediated induction of Cyp3a by black cohosh |
| Q90925452 | Propranolol is a mechanism-based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6-transgenic mice: Effects on activity and drug responses |
| Q93023565 | Publisher Correction: Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome |
| Q73481701 | Recent update on the PPARα-null mouse |
| Q127060100 | Reverse metabolomics for the discovery of chemical structures from humans |
| Q92609706 | SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis |
| Q72110177 | Styrene Metabolism by cDNA-Expressed Human Hepatic and Pulmonary Cytochromes P450 |
| Q44608946 | T Cell-Specific Disruption of Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Gene Causes Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Thymic Involution |
| Q28290813 | The CYP2 A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis |
| Q91353502 | The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation |